Jing-Jing Zhao

机构：Dalian Medical University, First Affiliated Hospital of Dalian Medical University · ORCID：0009-0004-1808-3534

发表论文 41 篇 · 总被引 1872 次 · h-index 28

代表论文

• A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma (2015 · Oncotarget · 被引 111)
• IL-17 induces antitumor immunity by promoting beneficial neutrophil recruitment and activation in esophageal squamous cell carcinoma (2017 · OncoImmunology · 被引 92)
• Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytes (2017 · OncoImmunology · 被引 90)
• The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma (2016 · Journal of Cancer · 被引 76)
• Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma (2014 · Journal of Translational Medicine · 被引 75)
• Cytotoxic T lymphocyte antigen-4 expression in esophageal carcinoma: implications for prognosis (2016 · Oncotarget · 被引 72)